| Literature DB >> 34673175 |
Jagdish Khubchandani1, Nirbachita Biswas2, Toheeb Mustapha3, Sabrina Talbert4, Shafik Dharamsi5.
Abstract
Entities:
Keywords: COVID-19; College; Student; University; Vaccination; Vaccine
Mesh:
Substances:
Year: 2021 PMID: 34673175 PMCID: PMC8527841 DOI: 10.1016/j.bbi.2021.10.006
Source DB: PubMed Journal: Brain Behav Immun ISSN: 0889-1591 Impact factor: 7.217
Summary of Worldwide COVID-19 Vaccination Refusal Rates and Reasons in College Students [Referred in Supplementary Materials
| Barello et. al. 2020 | ItalyNA | 735 | 13.9% | Reasons: Complexity of information and contrasting feelings.Enablers: High awareness, health background, and literacy. |
| Synnott, 2020 | USA NA | 591 | 29.8% | Reasons: Concerns about vaccine safety, side effects, and lack of information.Enablers: Male gender |
| Biswas et. al. 2021 | BangladeshNA | 322 | 32.3% | Reasons: Concerns about vaccine side effects, efficacy, low familiarity with vaccine.Enablers: Belief that vaccine will stop the spread of COVID-19 |
| Baloran,2020 | PhilippinesMay 2020 | 530 | 18.7% | Reasons: Concerns about vaccine safety, side effects, and health risks.Enablers: Business, economics, and education disciplines (i.e., non-media students) |
| Guzoglu et. al, 2021 | Cyprus/TurkeyJune 2020 | 327 | 15.5% | Reasons: Concerns about side-effects and efficacy, trust in own immune system.Cultural factors and/or the governments of these countries. |
| Pastorino et. al, 2021 | ItalyJuly 2020 | 162* | 18.5% | Reasons: Lower grade/education level in college, and lower perceived severity of COVID-19.Enablers: Male gender, flu vaccination history, and higher perceived risk of COVID-19 infection. |
| Patil et. al., 2021 | USAJuly 2020 | 256 | 51.5% | Reasons: Black race, republican party affiliation, lower concerns about COVID-19 infection.Enablers: Higher health literacy, higher perceived risk and severity of COVID-19 infection. |
| Gruner et. al. 2021 | GermanyAug 2020 | 1,249* | 14.3% | Reasons: Low trust in government and healthcare system, and lower perceived risk of COVID-19.Enablers: Male gender and fear of COVID-19 related infection and risks. |
| Mant et. al., 2021 | CanadaSept 2020 | 1,269 | 19.9% | Reasons: Concerns about insufficient testing, safety, and side effects. Mistrust in govt/pharma.Enablers: Affected by or higher perceived severity of COVID-19, recommendation by a doctor. |
| Qiao et. al. 2020 | USAOct 2020 | 1062 | 24.3% | Reasons: Concerns about vaccine safety, effectiveness, characteristics (i.e., country producing, speedy development, & vaccine administration methods), social media information/usage.Enablers: Duration of protection, accessibility, and receiving authoritative and trusted advice. |
| Mo et. al., 2021 | ChinaNov 2020 | 6922 | 21.1% | Reasons: Younger age, lower education grade in college, and social media usage.Enablers: Male gender, higher perceived benefits of vaccines, and positive descriptive norms. |
| Graupensperger et. al. 2020 | USANov 2020 | 647 | 8.4% | Reasons: Concerns about side effects & efficacy, speedy development/inadequate testing of vaccines, and vaccines could cause COVID-19 infections or make sick.Enablers: Social norms and peer perceptions, and having health insurance |
| Szymd et. al. 2021 | PolandDec 2020 | 1284* | 21.7% | Reasons: Concerns about side effects and complications of COVID vaccine, civil rights limitations.Enablers: History of vaccinations, higher grade in college, fear of COVID-19 spread. |
| Bai et. al. 2021 | ChinaJan 2021 | 2881 | 23.7% | Reasons: Concerns about safety and efficacy of COVID vaccines, lower perceived risk of COVID-19Enablers: Urban resident, encouraged by family, trust in vaccine benefits/effects. |
| Tavolacci, et. al. 2021 | FranceJan 2021 | 3,089 | 17.1% | Reasons: Concerns about side effects, rapid development of vaccine, wait for more information.Enablers: Male gender, older age, perceived risk of COVID-19 to self and others, vaccine trust. |
| Tsegaw Taye et. al., 2021 | EthiopiaJan 2021 | 134* | 43.3% | Reasons: Concerns about side effects, efficacy, & information, low perceived risk of COVID-19Enablers: Higher knowledge of COVID and family members’ engagement in COVID-19 prevention |
| Dratva et. al., 2021 | SwitzerlandJan 2021 | 1297 | 21.5% | Reasons: Lower perceived risk of COVID and confidence in vaccines, and information overload.Enablers: Male gender, older age, past flu vaccination, trust in the government strategy |
| Al-Mulla et. al, 2021 | QatarFeb 2021 | 231* | 50.2% | Reasons: Concerns about safety, side effects, efficacy, speedy trials, and low trust in vaccines.Enablers: Male gender, higher age & education level, flu vaccination history, travel requirements. |
| Walker et. al. 2021 | ChinaMarch 2021 | 330 | 30.6% | Reasons: Concerns about side effects, affordability, and authenticity of COVID-19 vaccines.Enablers: High knowledge and perceived risk of COVID-19 infection, trust in vaccine |
| Varol et. al. 2021 | NetherlandsMarch 2021 | 434 | 20% | Reasons: Concerns about safety, side effects, and rapid development of COVID-19 vaccines.Enablers: Trust in government, quality control, and the pharmaceutical industry. Higher self-efficacy and risk perception, prosocial norms and trust about vaccines. |
| Kecojevic et. al. 2021 | USAMarch 2021 | 457 | 36.3% | Reasons: Concerns about safety, efficacy, side effects. Mistrust in vaccine related information.Enablers: Older age, Whites, flu vaccination history, family member got vaccine. |
| Sharma et. al. 2021 | USAMarch 2021 | 282 | 47.5% | Reasons: Political affiliation, lower belief in vaccine benefits, lower confidence. |
| Galle et. al. 2021 | ItalyApr 2021 | 3,226 | 2% | Reasons: Concerns about vaccine safety and efficacy, and older age and grade in college.Enablers: Male gender, annual flu vaccination history, greater knowledge about vaccines. |
| Almalki et. al., 2021 | Saudi ArabiaApril 2021 | 407 | 6.2% | Reasons: Concerns of side effects & expedited trials, lack of trust & belief of no need for vaccineEnablers: Past flu vaccination, trust in government, health system, and community leaders. |
| Salerno et. al., 2021 | ItalyMay 2021 | 2667 | 13.3% | Reasons: Negative attitude towards vaccines & medicine, higher conspiracy and negative beliefs about side effects, efficacy, importance of vaccines and speedy trials of the COVID-19 vaccines.Enablers: Male sex, previous COVID test, higher agreeableness, and emotional stability. |
| Nwangwu et. al., 2021 | NigeriaMay 2021 | 364 | 50% | Reasons: Indifference towards and disagreement with effective curing and protecting vaccine and treatment modalities for COVID-19 in Nigeria. Enablers: NA |
| Riad et. al., 2021 | Czech RepublicJune 2021 | 793 | 22.9% | Reasons: Concerns about side effects and rushed testing of vaccines, lower knowledge, lack of information, and trust in pharma/healthcare providers, social media.Enablers: Male sex, older age, flu vaccination history, high perceived risk of COVID-19 |
| 17countries | 31, 948Students | 22%95%Ci=(18.5-26.1) |
∗indicates that the participants were part of a larger sample. A total of 27 studies with 31,948 participants have been included in this Table. Data collection month
instead of publication date for the study have been arranged in chronological order in the table. NA indicates that the data collection period was not mentioned.